2nd Quarter - Report
CLARK STREET ASSOCIATES for QORVO
Client
Income
$140,000
Expenses
—
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues related to COVID testing - no specific legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HAMMA | — |
Defense DEF
National Defense Authorization Act of FY 2022 - issues related to defense technology.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HAMMA | — |
Health Issues HCR
Issues related to COVID testing - no specific legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HAMMA | — |
Budget/Appropriations BUD
Department of Defense Appropriations for FY 2022 - issues related to defense technology.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HAMMA | — |
Computer Industry CPI
Issues related to broadband technology and investment - no specific legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HAMMA | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| QORVO BIOTECHNOLOGIES, LLC | Bend, OR, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.